Use of biomarkers in clinical trials.

被引:0
|
作者
Ransohoff, DF [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2768S / 2768S
页数:1
相关论文
共 50 条
  • [1] Incorporating biomarkers into adaptive clinical trials.
    Trippa, Lorenzo
    Wen, Patrick Y.
    Alexander, Brian Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Establishing digital biomarkers for clinical trials.
    Thomas, Neil
    Mattek, Nora
    Riley, Thomas
    Witter, Phelps
    Reynolds, Christina
    Austin, Johanna
    Sharma, Nicole
    Marcoe, Jennifer
    Kaye, Jeffrey
    [J]. NEUROLOGY, 2018, 90
  • [3] Performance characteristics of common immunologic biomarkers used in clinical trials.
    Goodell, V.
    Macleod, B.
    Slota, M.
    Disis, M. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 32S - 32S
  • [4] NGS panels' capture of biomarkers associated with targeted therapies in clinical trials.
    Fox, John Leonard
    Daniel, Sugganth
    Abrol, Manavi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Ancient clinical trials.
    Lewis, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 83 - 84
  • [7] Glycitein for clinical trials.
    Verbruggen, MA
    Olieman, K
    [J]. JOURNAL OF NUTRITION, 2002, 132 (03): : 601S - 601S
  • [8] Use of modernized eligibility criteria in pancreatic cancer clinical trials.
    Riner, Andrea N.
    Freudenberger, Devon Clemons
    Herremans, Kelly M.
    Neal, Daniel W.
    Vudatha, Vignesh
    George, Thomas J.
    Trevino, Jose G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Advancement in KRAS clinical trials.
    Yeung, Wayne
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [10] Clinical trials. A pending subject
    Gil-Extremera, B.
    Jimenez-Lopez, P.
    Mediavilla-Garcia, J. D.
    [J]. REVISTA CLINICA ESPANOLA, 2018, 218 (03): : 137 - 141